Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients

被引:115
|
作者
Bahnassy, AA [1 ]
Zekri, ARN
El-Houssini, S
El-Shehaby, AMR
Mahmoud, MR
Abdallah, S
El-Serafi, M
机构
[1] Cairo Univ, Natl Canc Inst, Dept Pathol, Cairo, Egypt
[2] Cairo Univ, Natl Canc Inst, Dept Canc Biol, Virol & Immunol Unit, Cairo, Egypt
[3] Cairo Univ, Kasr El Eini Sch Med, Dept Biochem, Cairo, Egypt
[4] Cairo Univ, Kasr El Eini Sch Med, Dept Pathol, Cairo, Egypt
[5] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo, Egypt
关键词
D O I
10.1186/1471-230X-4-22
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Colorectal cancer is a common cancer all over the world. Aberrations in the cell cycle checkpoints have been shown to be of prognostic significance in colorectal cancer. Methods: The expression of cyclin D1, cyclin A, histone H3 and Ki-67 was examined in 60 colorectal cancer cases for co-regulation and impact on overall survival using immunohistochemistry, southern blot and in situ hybridization techniques. Immunoreactivity was evaluated semi quantitatively by determining the staining index of the studied proteins. Results: There was a significant correlation between cyclin D1 gene amplification and protein overexpression (concordance = 63.6%) and between Ki-67 and the other studied proteins. The staining index for Ki-67, cyclin A and D1 was higher in large, poorly differentiated tumors. The staining index of cyclin D1 was significantly higher in cases with deeply invasive tumors and nodal metastasis. Overexpression of cyclin A and D1 and amplification of cyclin D1 were associated with reduced overall survival. Multivariate analysis shows that cyclin D1 and A are two independent prognostic factors in colorectal cancer patients. Conclusions: Loss of cell cycle checkpoints control is common in colorectal cancer. Cyclin A and D1 are superior independent indicators of poor prognosis in colorectal cancer patients. Therefore, they may help in predicting the clinical outcome of those patients on an individual basis and could be considered important therapeutic targets.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] The prognostic value of cyclin D1 in renal cell carcinoma
    Lima, M. S.
    Pereira, R. A.
    Costa, R. S.
    Tucci, S.
    Dantas, M.
    Muglia, V. F.
    Ravinal, R. C.
    Barros-Silva, G. E.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (05) : 905 - 913
  • [42] The prognostic value of cyclin D1 in renal cell carcinoma
    M. S. Lima
    R. A. Pereira
    R. S. Costa
    S. Tucci
    M. Dantas
    V. F. Muglia
    R. C. Ravinal
    G. E. Barros-Silva
    International Urology and Nephrology, 2014, 46 : 905 - 913
  • [43] Clinicopathological and prognostic significance of cyclin D1 amplification in patients with breast cancer: a meta-analysis
    He, Qi
    Wu, Jingxun
    Liu, Xin-Li
    Ma, Yi-Han
    Wu, Xiao-Ting
    Wang, Wen-Yi
    An, Han-Xiang
    JOURNAL OF BUON, 2017, 22 (05): : 1209 - 1216
  • [44] The prognostic value of cyclin D1 in breast cancer patients treated with hormonal therapy: A pilot study
    Todorovic-Rakovic, Natasa
    Milovanovic, Jelena
    Durosaro, Samuel Olutunde
    Radulovic, Marko
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 222
  • [45] Prognostic Utility of Cyclin D1 in Invasive Breast Carcinoma
    Parvin, Tamanna
    Das, Chhanda
    Choudhury, Manoj
    Chattopadhyay, Bitan Kumar
    Mukhopadhyay, Madhumita
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2019, 10 (01) : 167 - 173
  • [46] Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients
    Hwang, TS
    Han, HS
    Hong, YC
    Lee, HJ
    Paik, NS
    PATHOLOGY INTERNATIONAL, 2003, 53 (02) : 74 - 80
  • [47] Cyclin D1 goes metabolic: Dual functions of cyclin D1 in regulating lipogenesis
    Knudsen, Karen E.
    CELL CYCLE, 2012, 11 (19) : 3533 - 3534
  • [48] Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer
    Soni Kumari
    Shyam Babu Puneet
    Suresh Singh Prasad
    Mohan Yadav
    A. Kumar
    V. K. Khanna
    Gopal Dixit
    Sunita Nath
    Gopeshwar Singh
    Medical Oncology, 2016, 33
  • [49] Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer
    Kumari, Soni
    Puneet
    Prasad, Shyam Babu
    Yadav, Suresh Singh
    Kumar, Mohan
    Khanna, A.
    Dixit, V. K.
    Nath, Gopal
    Singh, Sunita
    Narayan, Gopeshwar
    MEDICAL ONCOLOGY, 2016, 33 (05)
  • [50] Cyclin D1 and prognosis in human breast cancer
    Gillett, C
    Smith, P
    Gregory, W
    Richards, M
    Millis, R
    Peters, G
    Barnes, D
    INTERNATIONAL JOURNAL OF CANCER, 1996, 69 (02) : 92 - 99